Search results
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Sanofi SA...
Sanofi (NASDAQ:SNY) Shares Acquired by Putnam Investments LLC
ETF DAILY NEWS· 1 day agoPutnam Investments LLC boosted its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 25.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,342,709 ...
Exploring Three Top Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 14 hours agoIn recent trading sessions, the French stock market has shown resilience, with the CAC 40 Index...
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 24 hours agoSanofi, which records sales of Dupixent, reported $11.6 billion in sales last year. This year, sales...
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
InvestorPlace· 6 days agoIn a meme frenzy, any positive news related to a company has a magnified impact on the stock price....
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 2 days agoPrice Performance Over the past year, Charles River shares have risen 4.4% compared with the...
Questor: Investors are undervaluing this London company’s pubs and hotels
The Telegraph via Yahoo Finance· 3 days agoWe are hopefully not tempting providence by taking a fresh look at Fuller Smith & Turner ahead of...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoThe French pharmaceutical company anticipates peak sales of over EUR500 million for its drug marketed as Iqirvo... think Iqirvo’s approval should be...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 6 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
Goldman Sachs raises Royalty Pharma stock target on deal activity By Investing.com
Investing.com· 6 days agoOn Friday, Goldman Sachs (NYSE:GS) updated its financial model for Royalty Pharma (NASDAQ:RPRX),...
